15-50449404-A-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_005154.5(USP8):c.254A>C(p.Tyr85Ser) variant causes a missense change. The variant allele was found at a frequency of 0.000026 in 1,574,586 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005154.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
USP8 | NM_005154.5 | c.254A>C | p.Tyr85Ser | missense_variant | Exon 4 of 20 | ENST00000307179.9 | NP_005145.3 | |
USP8 | NM_001128610.3 | c.254A>C | p.Tyr85Ser | missense_variant | Exon 4 of 20 | NP_001122082.1 | ||
USP8 | NM_001283049.2 | c.105-9596A>C | intron_variant | Intron 2 of 16 | NP_001269978.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152208Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000430 AC: 1AN: 232394Hom.: 0 AF XY: 0.00000793 AC XY: 1AN XY: 126052
GnomAD4 exome AF: 0.0000267 AC: 38AN: 1422378Hom.: 0 Cov.: 28 AF XY: 0.0000283 AC XY: 20AN XY: 706856
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74358
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia Uncertain:1
This sequence change replaces tyrosine with serine at codon 85 of the USP8 protein (p.Tyr85Ser). The tyrosine residue is moderately conserved and there is a large physicochemical difference between tyrosine and serine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with USP8-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at